Thursday, March 21, 2024 10:47:46 AM
from Q4 CC;
...we now have a path to profitability entirely independent of the scale-up of our biomass conversion technology and related manufacturing plant construction. These initiatives are led by our all-PET caps and closures business, a highly differentiated solution for the over $65 billion caps and closures market.
.
If profitable numbers are possible as soon as '25 there must be someone running trials now and are ready for licensing? Independent of scale-up is a huge statement. The partners looking to get into PET caps will be using in house materials.
Gets better;
Other near-term revenue-generating technologies are in development. Like our all-PET caps and closures, these new applications enabled by Origin technologies are NOT DEPENDENT ON ORIGIN 1 OR ORIGIN 2 FOR PRODUCTION AND sale but capable of using materials produced from these plants. These applications leverage Origin’s chemical expertise, depth of application knowledge, and intellectual property, with further details to be provided as development progresses
Recent ORGN News
- Origin Materials Partners with IMDvista on World’s First PET Cap and Closure Manufacturing System • Business Wire • 05/02/2024 11:00:00 AM
- Origin Materials Announces First Quarter 2024 Earnings Release Date and Conference Call • Business Wire • 05/01/2024 08:01:00 PM
- Origin Materials Partners with PackSys Global on World’s First PET Cap and Closure Manufacturing System • Business Wire • 04/30/2024 11:00:00 AM
- Origin Materials Converts Wood Residue Feedstock into Sustainable Intermediates at Commercial-Scale Plant • Business Wire • 04/03/2024 11:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 09:24:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 09:19:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:36:39 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:35:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 09:34:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:11:53 PM
- Origin Materials, Inc. Reports Operating and Financial Results for Fourth Quarter and Full Year 2023 • Business Wire • 02/29/2024 09:09:00 PM
- Origin Materials Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call • Business Wire • 02/15/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 05:12:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:31:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:45:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:40:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:21:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:20:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:19:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:27:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:26:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:25:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:17:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/13/2023 10:08:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/13/2023 09:37:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM